Literature DB >> 26652344

Swelling of poly(N-isopropylacrylamide) P(NIPA)-based hydrogels with bacterial-synthesized prodigiosin for localized cancer drug delivery.

Y Danyuo1, S Dozie-Nwachukwu2, J D Obayemi3, C J Ani4, O S Odusanya2, Y Oni5, N Anuku6, K Malatesta5, W O Soboyejo7.   

Abstract

We present the results of swelling experiments on poly(N-isopropylacrylamide) P(NIPA)-based hydrogels. The swelling characteristics of P(NIPA)-based homo-polymer and P(NIPA)-based co-polymers with Acrylamide (AM) and Butyl Methacrylate (BMA), were studied using weight gain experiments. The swelling due to the uptake of biosynthesized cancer drug, prodigiosin (PG), was compared to swelling in controlled environments (distilled water (DW), paclitaxel™ (PT) and bromophenol blue (BB)). PG was synthesized with Serratia marcescens (SM) subsp. marcescens bacteria. The mechanisms of drug diffusion and swelling of P(NIPA)-based hydrogels are also elucidated along with characterizing the heterogeneous porous structure of the P(NIPA)-based hydrogels. High Performance Liquefied Chromatography (HPLC) analysis revealed the purity of the biosynthesized prodigiosin to be 92.8%. PG was then absorbed by P(NIPA)-based hydrogels at temperatures between 28-48°C. This is a temperature range that might be encountered during the implantation of biomedical devices for localized cancer treatment via drug delivery and hyperthermia. The results obtained are shown to provide insights for the design of implantable biomedical devices for the localized treatment of breast cancer.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  P(NIPA)-based hydrogels;; Phase transition temperature; Prodigiosin;; Serratia marcescens;; Swelling kinetics;

Mesh:

Substances:

Year:  2015        PMID: 26652344     DOI: 10.1016/j.msec.2015.09.090

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  5 in total

1.  Extended pulsated drug release from PLGA-based minirods.

Authors:  Y Danyuo; O E Oberaifo; J D Obayemi; S Dozie-Nwachukwu; C J Ani; O S Odusanya; M G Zebaze Kana; K Malatesta; W O Soboyejo
Journal:  J Mater Sci Mater Med       Date:  2017-03-01       Impact factor: 3.896

2.  Polymeric composite devices for localized treatment of early-stage breast cancer.

Authors:  Kwabena Kan-Dapaah; Nima Rahbar; Wole Soboyejo
Journal:  PLoS One       Date:  2017-02-28       Impact factor: 3.240

3.  The Influence of Anionic Initiator on the Selected Properties of Poly-N-Isopropyl Acrylamide Evaluated for Controlled Drug Delivery.

Authors:  Agnieszka Gola; Tomasz Knysak; Witold Musial
Journal:  Molecules       Date:  2016-12-26       Impact factor: 4.411

4.  Anomalous Release Kinetics of Prodigiosin from Poly-N-Isopropyl-Acrylamid based Hydrogels for The Treatment of Triple Negative Breast Cancer.

Authors:  Y Danyuo; C J Ani; A A Salifu; J D Obayemi; S Dozie-Nwachukwu; V O Obanawu; U M Akpan; O S Odusanya; M Abade-Abugre; F McBagonluri; W O Soboyejo
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

Review 5.  Prodigiosin: a promising biomolecule with many potential biomedical applications.

Authors:  German A Islan; Boris Rodenak-Kladniew; Nehuen Noacco; Nelson Duran; Guillermo R Castro
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.